In the present study, we examined patterns of A-myb expression in the kainic acid (KA)-treated mouse hippocampus. Western blot analysis revealed that A-myb expression was dramatically increased in brain 3 days after KA treatment, and was sustained for more than 7 days. A-myb immunoreactivity was restricted to hippocampal neurons in control mice. Three days after KA treatment, strong A-myb immunoreactivity was observed in reactive astrocytes throughout the CA3 region. Thereafter, A-myb immunoreactive astrocytes gradually concentrated around the CA3 region in parallel with selective neuronal loss, and only a few A-myb immunoreactive astrocytes persisted in the CA3 region 14 days after KA treatment. These findings suggest that the A-myb plays a role in the reactive gliosis signaling pathway in KA-induced excitotoxic lesions.
A-myb Reactive astrocytes Kainic acid Hippocampus
This study was supported by grant no 21-2004-037 from the Seoul National University Hospital Research Fund, and in part by year 2006 the Second stage of BK 21 Project.
Ness SA (1996) The Myb oncoprotein: regulating a regulator. Biochim Biophys Acta 1288:F123–139PubMedGoogle Scholar
Foos G, Grimm S, Klempnauer KH (1994) The chicken A-myb protein is a transcriptional activator. Oncogene 9:2481–2488PubMedGoogle Scholar
Trauth K, Mutschler B, Jenkins NA et al (1994) Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. EMBO J 13:5994–6005PubMedGoogle Scholar
Golay J, Erba E, Bernasconi S et al (1994) The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt’s lymphoma cell lines. J Immunol 153:543–553PubMedGoogle Scholar
Sleeman JP (1993) Xenopus A-myb is expressed during early spermatogenesis. Oncogene 8:1931–1941PubMedGoogle Scholar
Weston K, Bishop JM (1989) Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58:85–93PubMedCrossRefGoogle Scholar
Sitzmann J, Noben-Trauth K, Klempnauer KH (1995) Expression of mouse c-myb during embryonic development. Oncogene 11:2273–2279PubMedGoogle Scholar
Jeon GS, Shin DH, Cho SS (2004) Induction of transcription factor c-myb expression in reactive astrocytes following intracerebroventricular kainic acid injection in mouse hippocampus. Neurosci Lett 360:13–16PubMedCrossRefGoogle Scholar
Cho J, Lee SH, Seo JH et al (2002) Increased expression of phosphatase and tensin homolog in reactive astrogliosis following intracerebroventricular kainic acid injection in mouse hippocampus. Neurosci Lett 334:131–134PubMedCrossRefGoogle Scholar
Laursen SE, Belknap JK (1986) Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16:355–357PubMedCrossRefGoogle Scholar
Jeon GS, Park SW, Kim DW et al (2004) Glial expression of the 90-kDa heat shock protein (HSP90) and the 94-kDa glucose-regulated protein (GRP94) following an excitotoxic lesion in the mouse hippocampus. Glia 48:250–258PubMedCrossRefGoogle Scholar
Ness SA (2003) Myb protein specificity: evidence of a context-specific transcription factor code. Blood Cells Mol Dis 31:192–200PubMedCrossRefGoogle Scholar